Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

Inclusion Criteria

• •1. Adult (age\>18 years);
• •2. positive rapid HIV test;
• •3. ability to provide informed consent;
• •4. HIV RNA \> 200 copies/ml;
• •5. creatinine clearance \> 30 mg/dl as measured by serum creatinine;
• •6. no allergy to bictegravir/emtricitabine/tenofovir alafenamide (BFTAF) as indicated by patient history and self-reported allergies.